Superworth

Surgery Partners revenue SGRY

Sales by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
$3.4B
Latest quarter, Q2 FY26
$848.9M
+3% on a year earlier
Fiscal year 2025
$3.3B
+6% on the year before

Surgery Partners' revenue was $3.4B over the twelve months to Jun 30, 2026, up 4% on a year earlier.

In its latest quarter, Q2 FY26, it was $848.9M, up 3% on the same quarter a year before.

Over the five fiscal years to FY2025 it grew 12% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$3.3B+6%
FY2024$3.1B+14%
FY2023$2.7B+8%
FY2022$2.5B+14%
FY2021$2.2B+20%
FY2020$1.9B+2%
FY2019$1.8B+3%
FY2018$1.8B+55%
FY2016$1.1B+19%
FY2015$959.9M+138%
FY2014$403.3Mn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$848.9M+3%$3.4B
Q1 FY26$810.9M+4%$3.3B
Q4 FY25$885M+2%$3.3B
Q3 FY25$821.5M+7%$3.3B
Q2 FY25$826.2M+8%$3.2B
Q1 FY25$776M+8%$3.2B
Q4 FY24$864.4M+18%$3.1B
Q3 FY24$770.4M+14%$3B
Q2 FY24$762.1M+14%$2.9B
Q1 FY24$717.4M+8%$2.8B
Q4 FY23$735.4M+4%$2.7B
Q3 FY23$674.1M+9%$2.7B

Against its peers

Companies in Medical - Care Facilities nearest Surgery Partners' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
SGRYSurgery Partners$3.4B+4% a year
NHCNational Healthcare$1.6B+7% a year
AVAHAveanna Healthcare$2.6B+20% a year
PRVAPrivia Health$2.4B+24% a year
MDPediatrix Medical$2B+2% a year
ADUSAddus HomeCare$1.5B+16% a year
PGNYProgyny$1.3B+6% a year
OPCHOption Care Health$5.7B+6% a year
SHCSotera Health$1.2B+8% a year
LFSTLifeStance Health$1.6B+20% a year
CONConcentra Group Holdings Parent$2.3B+14% a year
Peer median$1.8B

Where Surgery Partners ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Surgery Partners

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.